Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Alp, Keziban Merve (1) Birchmeier, Walter Prof. Dr. (2) Blankenstein, Thomas Prof. Dr. (1) Dahlmann, Mathias Dr. (5) Grybowski, Andrea (1) Hübner, Norbert Prof. Dr. (1) Ivics, Zoltan Dr. (26) Izsvak, Zsuzsanna Dr. (29) Kobelt, Dennis Dr. (9) Mertins, Philipp Dr. (3) Pande, Amit Dr. (1) Pezzutto, Antonio Prof. Dr. (1) Popp, Oliver Dr. (2) Rehm, Armin Dr. (1) Röefzaad, Claudia (1) Saar, Kathrin Dr. (1) Schlag, Peter M. Prof. Dr. (109) Schroeder, Leif Dr. (1) Simon, Mareike Dr. (1) Sporbert, Anje Dr. (1) Stein, Ulrike Prof. Dr. (34) Uckert, Wolfgang Prof. Dr. (1) Walther, Wolfgang Prof. Dr. (23) Wanker, Erich Prof. Dr. (1) Willimsky, Gerald Dr. (1) Willnow, Thomas Prof. Dr. (1) Wolf, Jana Prof. Dr. (1) (-) Smith, Janice (4) 2006 (1) (-) 2008 (1) (-) 2009 (3) 2011 (1) 2012 (1) 2013 (2) 2014 (1) 2016 (2) 2017 (2) 2020 (2) (-) 2021 (1) 2022 (1) 2023 (2) AG Schreiber [ECRC] (1) Animal Phenotyping (1) Bioinformatics and Omics Data Science (2) Biology of Malignant Lymphomas (1) Cancer Genetics and Cellular Stress Responses (1) Experimental Ultrahigh-Field MR (28) Innate Immunity & Neuroinflammation (3) Interdisciplinary Retina Research (16) Magnetic Resonance (28) Microenvironmental Regulation in Autoimmunity and Cancer (2) (-) Mobile DNA (1) Molecular Biology of Peptide Hormones (2) Molecular Cardiovascular Research (1) Molecular Pathways in Cortical Development (1) Nephrology and Inflammatory Vascular Diseases (2) Neural Circuits and Behaviour (1) Neuroimmunology Laboratory (3) Out-patient Clinic for Neuroimmunology (64) Pathogenesis of ANCAinduced Glomerulonephritis (16) Proteomics (1) Systems Biology of Gene Regulatory Elements (1) Translational Neuroimmunology (8) (-) Translational Oncology of Solid Tumors (4) 5 Results: Active Filter: Smith, JaniceMobile DNATranslational Oncology of Solid Tumors200820092021 Sort: Result score Newest to oldest Oldest to newest June 01, 2009 / Nat Genet Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates L. Mates M.K. Chuah E. Belay B. Jerchow N. Manoj A. Acosta-Sanchez D.P. Grzela A. Schmitt K. Becker J. Matrai L. Ma E. Samara-Kuko C. Gysemans D. Pryputniewicz C. Miskey B. Fletcher T. Vandendriessche Z. Ivics Z. Izsvak August 01, 2009 / Cell Cycle MACC1 controls Met: What a difference an Sp1 site makes U. Stein J. Smith W. Walther F. Arlt January 01, 2009 / Nat Med MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis U. Stein W. Walther F. Arlt H. Schwabe J. Smith I. Fichtner W. Birchmeier P.M. Schlag May 02, 2008 Improved tumour response by laser light treatment G. Graschew J. Smith S. Rakowsky T.A. Roelofs P.M. Schlag U. Stein August 26, 2021 / Oncogene The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis D. Kobelt D. Perez-Hernandez C. Fleuter M. Dahlmann F. Zincke J. Smith R. Migotti O. Popp S. Burock W. Walther G. Dittmar P. Mertins U. Stein
June 01, 2009 / Nat Genet Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates L. Mates M.K. Chuah E. Belay B. Jerchow N. Manoj A. Acosta-Sanchez D.P. Grzela A. Schmitt K. Becker J. Matrai L. Ma E. Samara-Kuko C. Gysemans D. Pryputniewicz C. Miskey B. Fletcher T. Vandendriessche Z. Ivics Z. Izsvak
August 01, 2009 / Cell Cycle MACC1 controls Met: What a difference an Sp1 site makes U. Stein J. Smith W. Walther F. Arlt
January 01, 2009 / Nat Med MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis U. Stein W. Walther F. Arlt H. Schwabe J. Smith I. Fichtner W. Birchmeier P.M. Schlag
May 02, 2008 Improved tumour response by laser light treatment G. Graschew J. Smith S. Rakowsky T.A. Roelofs P.M. Schlag U. Stein
August 26, 2021 / Oncogene The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis D. Kobelt D. Perez-Hernandez C. Fleuter M. Dahlmann F. Zincke J. Smith R. Migotti O. Popp S. Burock W. Walther G. Dittmar P. Mertins U. Stein